Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 in the page footer.
    Difference
    0.1%
    Check dated 2026-03-21T14:29:01.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a backend version update with no user-facing changes.
    Difference
    0.1%
    Check dated 2026-03-06T23:04:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Minor version update noted: v3.4.2 has been added and v3.4.1 removed. This appears to be a maintenance change rather than a change to study data or user actions.
    Difference
    0.1%
    Check dated 2026-02-13T12:38:18.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no visible changes to study details or page layout are observed.
    Difference
    0.1%
    Check dated 2026-02-05T18:57:13.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T04:31:15.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T15:55:17.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.